Elsevier Nanocarriers for Drug-Targeting Brain Tumors (Micro and Nano Technologies)

Nanocarriers for Drug-Targeting Brain Tumors covers different types of nanocarriers and  their design and development for targeting drugs to the brain. The book also presents case studies and the mechanism of action of nanocarriers in drug targeting to a specific site. This helps researchers and clinicians understand the design, development and mechanism of action of nanocarriers. As brain tumors continue to be a significant health problem globally, and very complex for targeting drugs, conventional dosage forms are not very effective and side-effects are a major concern. Functionalized nanocarriers can address these problems. Furthermore, the targeting of nanocarriers is preferred for reducing toxicity and improving the effectiveness of the drugs. However, there is a need for understanding the design and development of formulation with the mechanism of action of nanocarriers for brain targeting. Review Provides information on the major nanomaterial types used for drug targeting and delivery to combat brain tumors From the Back Cover <p>Brain tumors continue to be a significant health problem globally. They include some of the most malignant tumors. It is reported that in future years is very challenging to treat them as the position is complex and targeting drugs to the various regions is very difficult. Conventional dosage forms are not very effective and side-effects are a major concern. Functionalized nanocarriers can address these problems. Furthermore, the targeting of nanocarriers is preferred for reducing toxicity and improving the effectiveness of the drugs. However, there is a need for understanding the design and development of formulation with the mechanism of action of nanocarriers for brain targeting.</p> <p><i>Nanocarriers for Drug-Targeting Brain Tumors </i>covers different types of nanocarrier, their design, and development for targeting drugs to the brain. The book also presents case studies and the mechanism of the action of nanocarriers in drug targeting to a specific site. This helps researchers and clinicians to understand the design, development and mechanism of action of nanocarriers.</p> About the Author Lalit Kumar, is Assistant Professor in the Department of Pharmaceutics, at Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, India. His area of research includes the development of nanocarriers for drug-targeting tumor cells in the colon, brain, breast, and lung. Yashwant Pathak, is Professor and Associate Dean for the Faculty Affairs at the College of Pharmacy, at the University of South Florida. Tampa, USA. His area of research is in health care education, nanotechnology, drug delivery systems and nutraceuticals.